Skip to content

Vertex Pharmaceuticals’ Orphan Drug Kalydeco And VX-809 Combination Phase II Data: Perspective

October 14, 2012

       An October 12, 2012 article gives a fresh perspective on Vertex Pharmaceuticals VX-809 and orphan drug Kalydeco combination Phase II data, presented at the North American Cystic Fibrosis Conference on October 11, 2012. 

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: